A. Avlamis

435 total citations
16 papers, 329 citations indexed

About

A. Avlamis is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, A. Avlamis has authored 16 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Medicine, 7 papers in Clinical Biochemistry and 5 papers in Infectious Diseases. Recurrent topics in A. Avlamis's work include Antibiotic Resistance in Bacteria (9 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Streptococcal Infections and Treatments (5 papers). A. Avlamis is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Streptococcal Infections and Treatments (5 papers). A. Avlamis collaborates with scholars based in Greece and United States. A. Avlamis's co-authors include Joseph Papaparaskevas, Ioanna Stefanou, N.J. Legakis, Chris Kosmidis, Mina Psichοgiou, Panayotis T. Tassios, Marina Toutouza, Anna Xanthaki, O. Paniara and E. Platsouka and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

A. Avlamis

16 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Avlamis Greece 11 152 123 91 77 73 16 329
N. A. C. Potz United Kingdom 6 112 0.7× 70 0.6× 115 1.3× 51 0.7× 76 1.0× 7 273
Carmen Rodríguez-Avial Spain 13 250 1.6× 89 0.7× 91 1.0× 77 1.0× 133 1.8× 24 427
Kang Gyun Park South Korea 12 191 1.3× 164 1.3× 99 1.1× 69 0.9× 171 2.3× 25 394
Kazuhisa Mezaki Japan 11 153 1.0× 110 0.9× 111 1.2× 93 1.2× 112 1.5× 42 378
Fawzia Alotaibi Saudi Arabia 11 146 1.0× 81 0.7× 103 1.1× 38 0.5× 120 1.6× 18 339
Elżbieta Stefaniuk Poland 10 120 0.8× 112 0.9× 143 1.6× 64 0.8× 160 2.2× 21 383
Naveen Grover India 13 152 1.0× 121 1.0× 175 1.9× 66 0.9× 70 1.0× 34 377
Ana Di Martino Argentina 7 211 1.4× 58 0.5× 71 0.8× 121 1.6× 52 0.7× 16 313
Yoko Takayama Japan 9 128 0.8× 49 0.4× 107 1.2× 80 1.0× 100 1.4× 42 348
Deena Sutter United States 8 99 0.7× 75 0.6× 139 1.5× 34 0.4× 90 1.2× 14 334

Countries citing papers authored by A. Avlamis

Since Specialization
Citations

This map shows the geographic impact of A. Avlamis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Avlamis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Avlamis more than expected).

Fields of papers citing papers by A. Avlamis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Avlamis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Avlamis. The network helps show where A. Avlamis may publish in the future.

Co-authorship network of co-authors of A. Avlamis

This figure shows the co-authorship network connecting the top 25 collaborators of A. Avlamis. A scholar is included among the top collaborators of A. Avlamis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Avlamis. A. Avlamis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Avlamis, A., Joseph Papaparaskevas, George L. Daikos, et al.. (2012). Incidence and risk factors for central vascular catheter-related bloodstream infections in a tertiary care hospital.. PubMed. 35(4). 429–37. 14 indexed citations
2.
3.
Kosmidis, Chris, Mina Psichοgiou, Panayotis T. Tassios, et al.. (2009). Prospective study of Klebsiella pneumoniae bacteremia:Risk factors and clinical significance of type VIM-1 metallo-beta-lactamases. Research Explorer (The University of Manchester). 2 indexed citations
4.
Papaparaskevas, Joseph, et al.. (2008). Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece. Journal of Antimicrobial Chemotherapy. 62(1). 137–141. 28 indexed citations
5.
Avlamis, A., et al.. (2008). Risk Factors for Coexistence of Fluoroquinolone Resistance and ESBL Production amongEnterobacteriaceaein a Greek University Hospital. Journal of Chemotherapy. 20(4). 452–457. 10 indexed citations
6.
Papaparaskevas, Joseph, et al.. (2007). Differences in the evolution of imipenem susceptibility among Klebsiella pneumoniae and Escherichia coli isolates during a 6-year period in a tertiary care hospital. International Journal of Antimicrobial Agents. 29(2). 197–200. 3 indexed citations
7.
Psichοgiou, Mina, Panayotis T. Tassios, A. Avlamis, et al.. (2007). Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. Journal of Antimicrobial Chemotherapy. 61(1). 59–63. 94 indexed citations
8.
Sipsas, Nikolaos V., et al.. (2006). Septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy. Diagnostic Microbiology and Infectious Disease. 55(4). 343–345. 22 indexed citations
9.
Avlamis, A., et al.. (2006). In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains. Diagnostic Microbiology and Infectious Disease. 55(3). 231–236. 17 indexed citations
10.
Papaparaskevas, Joseph, et al.. (2006). Two Cases of Infections Due to Multidrug-Resistant Bacteroides fragilis Group Strains. Journal of Clinical Microbiology. 44(9). 3465–3467. 33 indexed citations
11.
Papaparaskevas, Joseph, et al.. (2005). Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clinical Microbiology and Infection. 11(10). 820–824. 29 indexed citations
12.
Papaparaskevas, Joseph, et al.. (2003). Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in a Greek tertiary care hospital, over an 8-year-period. International Journal of Antimicrobial Agents. 21(6). 542–546. 11 indexed citations
13.
Kaufmann, Mary E., et al.. (2001). Characterisation of VanA and VanB elements from glycopeptide-resistant Enterococcus faecium from Greece. Journal of Medical Microbiology. 50(8). 682–687. 12 indexed citations
14.
Avlamis, A., et al.. (1989). Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates ofPseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 8(10). 917–919. 7 indexed citations
15.
Avlamis, A., et al.. (1989). In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipsendomonal antimicrobials. Journal of Antimicrobial Chemotherapy. 24(suppl A). 143–147. 15 indexed citations
16.
Kanellakopoulou, K., et al.. (1988). Surveillance study of resistance inHaemophilus species in Greece. European Journal of Clinical Microbiology & Infectious Diseases. 7(2). 186–188. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. A. C. Potz Breakdown of academic impact, for papers by Carmen Rodríguez-Avial Breakdown of academic impact, for papers by Kang Gyun Park Breakdown of academic impact, for papers by Kazuhisa Mezaki Breakdown of academic impact, for papers by Fawzia Alotaibi Breakdown of academic impact, for papers by Elżbieta Stefaniuk Breakdown of academic impact, for papers by Naveen Grover Breakdown of academic impact, for papers by Ana Di Martino Breakdown of academic impact, for papers by Yoko Takayama Breakdown of academic impact, for papers by Deena Sutter
Rankless by CCL
2026